Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 401–500 of 1,000
Zaccagnino, A., Managò, A., Leanza, L., Gontarewitz, A., Linder, B., Azzolini, M., Biasutto, L., Zoratti, M., Peruzzo, R., Legler, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11299 · Cited by 61
Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
Linden, C. V., & Corbet, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00159 · Cited by 62
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
Ganji, C., Muppala, V., Khan, M., Nagaraju, G. P., & Farran, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103469 · Cited by 58
Kumarasamy, V. M., Frangou, C. G., Wang, J., Wan, Y., Dynka, A., Rosenheck, H. R., Dey, P., Abel, E. V., Knudsen, E. S., & Witkiewicz, A. K. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2504 · Cited by 63
Minimal residual disease in cancer therapy – Small things make all the difference
Blatter, S., & Rottenberg, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.003 · Cited by 65
Metabolism and epigenetics of pancreatic cancer stem cells
Lanfranca, M. P., Thompson, J. K., Bednar, F., Halbrook, C. J., Lyssiotis, C. A., Lévi, B., & Frankel, T. L. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.008 · Cited by 60
Self-citationKuznetsova, D. A., Gaynanova, G. A., Vasileva, L. A., Sibgatullina, G., Samigullin, D., Sapunova, А. S., Voloshina, A. D., Galkina, I. V., Petrov, K. A., & Zakharova, L. Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01853k · Cited by 56
Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
Lucchetti, D., Tenore, C. R., Colella, F., & Sgambato, A. (2020) · Cancers · doi:10.3390/cancers12010171 · Cited by 61
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 59
Lyakhovich, A., & LLeonart, M. E. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1716341 · Cited by 58
Lamb, R., Ózsvári, B., Bonuccelli, G., Smith, D. L., Pestell, R. G., Martinez‐Outschoorn, U., Clarke, R. B., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5260 · Cited by 59
Yoshino, S., Hara, T., Nakaoka, H. J., Kanamori, A., Murakami, Y., Seiki, M., & Sakamoto, T. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.19 · Cited by 61
Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements
Seo, J. H., Agarwal, E., Bryant, K. G., Caino, M. C., Kim, E. T., Kossenkov, A. V., Tang, H., Languino, L. R., Gabrilovich, D. I., Cohen, A. R., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0595 · Cited by 58
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Vessoni, A. T., Filippi‐Chiela, E. C., Lenz, G., & Batista, L. F. Z. (2019) · Oncogene · doi:10.1038/s41388-019-1128-4 · Cited by 60
Ravà, M., D’Andrea, A., Nicoli, P., Gritti, I., Donati, G., Doni, M., Giorgio, M., Olivero, D., & Amati, B. B. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8723 · Cited by 54
Zhao, H., Chang, Y., Hu, Y., Mu, L., Liu, S., Huang, K., Li, Q., Li, X., Tao, D., & Qin, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.044 · Cited by 60
Targeting mitochondrial metabolism for metastatic cancer therapy
Passaniti, A., Kim, M. S., Polster, B. M., & Shapiro, P. S. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23436 · Cited by 65
The adaptor protein Miro1 modulates horizontal transfer of mitochondria in mouse melanoma models
Novák, J., Nahácka, Z., Oliveira, G. L., Brisudová, P., Dubisova, M., Dvorakova, S., Miklovicova, S., Dalecká, M., Puttrich, V., Grycová, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115154 · Cited by 59
Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
Johnson, J. M., Lai, S. Y., Cotzia, P., Cognetti, D. M., Luginbuhl, A., Pribitkin, E. A., Zhan, T., Mollaee, M., Domingo‐Vidal, M., Chen, Y., et al. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.025 · Cited by 55
Essential Role for Oxidative Phosphorylation in Cancer Progression
Maiuri, M. C., & Kroemer, G. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.013 · Cited by 59
Modulation of Autophagy by Calcium Signalosome in Human Disease
Filippi‐Chiela, E. C., Viegas, M. S., Thomé, M. P. M., Buffon, A., Wink, M. R., & Lenz, G. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105171 · Cited by 57
Molecular Pathways Controlling Autophagy in Pancreatic Cancer
New, M. I., Acker, T. V., Long, J. S., Sakamaki, J.-I., Ryan, K. M., & Tooze, S. A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00028 · Cited by 60
Lu, Z., Xu, N., He, B., Pan, C., Lan, Y., Zhou, H., & Liu, X. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0512-6 · Cited by 53
Kshattry, S., Saha, A., Gries, P., Tiziani, S., Stone, E., Georgiou, G., & DiGiovanni, J. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0088-z · Cited by 52
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 57
Cancer Cell Dormancy in Metastasis
Summers, M. A., McDonald, M. M., & Croucher, P. I. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037556 · Cited by 59
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
Chen, W.-C., To, M. D., Westcott, P. M. K., Delrosario, R., Kim, I.-J., Philips, M. R., Tran, Q., Bollam, S., Goodarzi, H., Bayani, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24498-7 · Cited by 64
RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells
Wei, X., Xu, Y., Xu, F., Chaiswing, L., Schnell, D., Noel, T. J., Wang, C., Chen, J., Clair, D. K. S., & Clair, W. H. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0785 · Cited by 54
Kitajima, S., Yoshida, A., Kohno, S., Li, F., Suzuki, S., Nagatani, N., Nishimoto, Y., Sasaki, N., Muranaka, H., Wan, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.124 · Cited by 56
Cell death-based treatment of neuroblastoma
Valter, K., Zhivotovsky, B., & Gogvadze, V. G. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0060-1 · Cited by 59
Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition
Gale, M., Li, Y., Cao, J. P., Liu, Z. Z., Holmbeck, M. A., Zhang, M., Lang, S. M., Wu, L., DoCarmo, M., Gupta, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3985 · Cited by 52
Liu, P., Xing, N., Xiahou, Z., Yan, J., Lin, Z., & Zhang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368685 · Cited by 55
Acidosis orchestrates adaptations of energy metabolism in tumors
Groessl, S., Kalis, R., Snaebjornsson, M. T., Wambach, L., Haider, J., Andersch, F., Schulze, A., Palm, W., & Zuber, J. A. (2025) · Science · doi:10.1126/science.adp7603 · Cited by 67
Sakamoto, A., Kunou, S., Shimada, K., Tsunoda, M., Aoki, T., Iriyama, C., Tomita, A., Nakamura, S., Hayakawa, F., & Kiyoi, H. (2019) · Cancer Science · doi:10.1111/cas.13873 · Cited by 51
Park, S., Safi, R., Liu, X., Baldi, R., Liu, W., Liu, J., Locasale, J. W., Chang, C.-Y., & McDonnell, D. P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.066 · Cited by 51
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 59
Lorente, J., Velandia, C., Leal, J. A., Garcia‐Mayea, Y., Lyakhovich, A., Kondoh, H., & LLeonart, M. E. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12337 · Cited by 55
Devenport, S. N., Singhal, R., Radyk, M. D., Taranto, J., Kerk, S. A., Chen, B., Goyert, J. W., Jain, C., Das, N. K., Oravecz-Wilson, K. I., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.138835 · Cited by 56
Self-citationThe metabolic landscape of cancer stem cells
Dando, I., Pozza, E. D., Biondani, G., Cordani, M., Palmieri, M., & Donadelli, M. (2015) · IUBMB Life · doi:10.1002/iub.1426 · Cited by 50
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
Morandi, A., Giannoni, E., & Chiarugi, P. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.11.001 · Cited by 49
Reprogramming to developmental plasticity in cancer stem cells
O’Brien‐Ball, C., & Biddle, A. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.07.025 · Cited by 51
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition
Nguyen, T. T. T., Ishida, C. T., Shang, E., Shu, C., Torrini, C., Zhang, Y., Bianchetti, E., Sanchez‐Quintero, M. J., Kleiner, G., Quinzii, C. M., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910769 · Cited by 52
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Nelson, B. S., Lin, L., Kremer, D. M., Sousa, C. M., Cotta‐Ramusino, C., Myers, A. L., Ramos, J., Gao, T., Kovalenko, I., Wilder-Romans, K., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-019-0202-2 · Cited by 56
Self-citationSRC Kinase in Glioblastoma: News from an Old Acquaintance
Cirotti, C., Contadini, C., & Barilà, D. (2020) · Cancers · doi:10.3390/cancers12061558 · Cited by 54
Li, Z., Wang, Z., Tang, Y., Lu, X., Chen, J., Dong, Y., Wu, B., Wang, C., Liu, Y., Guo, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11808-3 · Cited by 52
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis
Chen, Z., Ho, I.-L., Soeung, M., Yen, E.-Y., Liu, J., Liang, Y., Rose, J. L., Srinivasan, S., Jiang, S., Chang, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37924-9 · Cited by 57
Self-citationLu, J., Dong, Q., Zhang, B., Wang, X., Ye, B., Zhang, F., Song, X., Gao, G., Mu, J., Wang, Z., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0616-9 · Cited by 51
RetractedOvercoming treatment resistance in cancer: Current understanding and tactics
Wu, G. J., Wilson, G., George, J., Liddle, C., Hebbard, L., & Qiao, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.018 · Cited by 52
Stress-Adaptive Response in Ovarian Cancer Drug Resistance
Amoroso, M. R., Matassa, D. S., Agliarulo, I., Avolio, R., Maddalena, F., Condelli, V., Landriscina, M., & Esposito, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.004 · Cited by 53
Quintela-Fandiño, M., Morales, S. M., Cortés-Salgado, A., Manso, L., Apala, J. V., Muñoz, M., Cudós, A. G., Fortuny, J. S., Gión, M., López‐Alonso, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2023 · Cited by 50
Yu, Z., Hu, P., Xu, Y., Bao, Q., Ni, D., Wei, C., & Shi, J. (2020) · Small · doi:10.1002/smll.201907233 · Cited by 47
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I
Jain, S., Hu, C., Kluza, J., Ke, W., Tian, G., Giurgiu, M., Bleilevens, A., Campos, A. R., Charbono, A., Stickeler, E., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.002 · Cited by 53
Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment
Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184351 · Cited by 53
Metabolic adaptations in cancer stem cells: A key to therapy resistance
Masoudi, M., Moti, D., Masoudi, R., Auwal, A., Hossain, M. M., Pronoy, T. U. H., Rashel, K. M., Gopalan, V., & Islam, F. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167164 · Cited by 55
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 55
Kareva, I. (2019) · Stem Cells · doi:10.1002/stem.3051 · Cited by 48
On ATG4B as Drug Target for Treatment of Solid Tumours—The Knowns and the Unknowns
Agrotis, A., & Ketteler, R. (2019) · Cells · doi:10.3390/cells9010053 · Cited by 48
Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies
Pranzini, E., Raugei, G., & Taddei, M. L. (2022) · Cancers · doi:10.3390/cancers14030547 · Cited by 60
Huang, J., Zhao, L., Zhou, X., Liu, L., Zheng, R., Deng, F., Liu, Y., Yu, X., Li, S., & Cheng, H. B. (2022) · Small · doi:10.1002/smll.202107467 · Cited by 50
Myeloid Cell–Derived Oxidized Lipids and Regulation of the Tumor Microenvironment
Hicks, K. C., Tyurina, Y. Y., Kagan, V. E., & Gabrilovich, D. I. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3054 · Cited by 49
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
Xu, Y., He, L., Fu, Q., & Hu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759015 · Cited by 52
Ojha, R., Tantray, I., Rimal, S., Mitra, S. S., Cheshier, S., & Lu, B. (2022) · Developmental Cell · doi:10.1016/j.devcel.2021.12.020 · Cited by 51
Exosomes: Potential for Early Detection in Pancreatic Cancer
Lu, L., & Risch, H. A. (2016) · Future Oncology · doi:10.2217/fon-2015-0005 · Cited by 84
Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation
Kitajima, S., & Takahashi, C. (2017) · Cancer Science · doi:10.1111/cas.13312 · Cited by 54
Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells
Barnes, E., Xu, Y., Benito, A., Herendi, L., Siskos, A., Aboagye, E. O., Nijhuis, A. M., & Keun, H. C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0777-y · Cited by 54
Karlstaedt, A., Barrett, M., Hu, R., Gammon, S. T., & Ky, B. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.05.008 · Cited by 51
Mitochondria: An intriguing target for killing tumour-initiating cells
Yan, B., Dong, L., & Neužil, J. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.12.007 · Cited by 51
Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
Chen, P.-Y., Muzumdar, M. D., Dorans, K. J., Robbins, R., Bhutkar, A., del Rosario, A., Mertins, P., Qiao, J., Schafer, A. C., Gertler, F., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2129 · Cited by 46
Gao, Y., Dorn, P., Liu, S., Deng, H., Hall, S. R. R., Peng, R., Schmid, R. A., & Marti, T. M. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1037-1 · Cited by 53
McGuirk, S., Audet-Delage, Y., Annis, M. G., Xue, Y., Vernier, M., Zhao, K., St‐Louis, C., Minarrieta, L., Patten, D. A., Morin, G., et al. (2021) · eLife · doi:10.7554/elife.65150 · Cited by 50
Circumventing senescence is associated with stem cell properties and metformin sensitivity
Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45
“High mitochondrial mass correlates with cancer stem cell properties (Farnie, Sotgia, & Lisanti, 2015), and in pancreatic tumors, the stem cell population has an increase in respiration and dependency on electron transport and oxidative phosphorylation (Sancho et al., 2015; Viale et al., 2014).”
BackgroundResultGampala, S., Shah, F., Lu, X., Moon, H., Babb, O., Ganesh, N. U., Sandusky, G. E., Hulsey, E. L., Armstrong, L., Mosley, A. L., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02046-x · Cited by 48
Understanding the Contribution of Lactate Metabolism in Cancer Progress: A Perspective from Isomers
Cai, M., Wan, J., Cai, K., Song, H., Wang, Y., Sun, W., & Hu, J. (2022) · Cancers · doi:10.3390/cancers15010087 · Cited by 50
Self-citationResistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us
Kumar, S., & Sherman, M. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087233 · Cited by 50
Hsu, M., Tsai, Y.-L., Lin, C.-H., Pan, M., Shan, Y., Cheng, T., Cheng, S. H.-C., Chen, L., & Hung, W.-C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0769-7 · Cited by 48
Sánchez‐Alvarez, R., Francesco, E. M. D., Fiorillo, M., Sotgia, F., & Lisanti, M. P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01776 · Cited by 53
Cao, Z., Weygant, N., Chandrakesan, P., Houchen, C. W., Peng, J., & Qu, D. (2020) · Cancers · doi:10.3390/cancers12123801 · Cited by 45
Praharaj, P. P., Patro, B. S., & Bhutia, S. K. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15401 · Cited by 47
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer
Ferrarini, I., Louie, A. D., Zhou, L., & El‐Deiry, W. S. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0962 · Cited by 49
Asymmetric Cell Division and Tumor Heterogeneity
Li, Z., Zhang, Y. Y., Zhang, H., Yang, J., Chen, Y., & Lu, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.938685 · Cited by 56
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 55
Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review
Kobayashi, H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11487 · Cited by 51
Non-lethal outcomes of engaging regulated cell death pathways in cancer
Kalkavan, H., Rühl, S., Shaw, J. J. P., & Green, D. R. (2023) · Nature Cancer · doi:10.1038/s43018-023-00571-6 · Cited by 49
Vaishampayan, P., & Lee, Y. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103288 · Cited by 43
Duan, H., Ren, J., Wei, S., Yang, Z., Li, C., Wang, Z., Li, M., Wei, Z., Liu, Y., Wang, X., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01410-8 · Cited by 49
Targeting mitochondrial RNA polymerase in acute myeloid leukemia
Bralha, F. N., Liyanage, S. U., Hurren, R., Wang, X., Son, M. H., Fung, T. A., Chingcuanco, F., Tung, A. Y. W., Andreazza, A. C., Psarianos, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6129 · Cited by 46
The impact of non-genetic heterogeneity on cancer cell death
Inde, Z., & Dixon, S. J. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1412395 · Cited by 42
Luo, J., Zeng, B., Tao, C., Lu, M., & Ren, G. (2020) · PeerJ · doi:10.7717/peerj.8754 · Cited by 46
Wu, P., Hong, S., Starenki, D., Oshima, K., Shao, H., Gestwicki, J. E., Tsai, S., & Park, J. (2020) · Oncogene · doi:10.1038/s41388-020-1285-5 · Cited by 46
Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
Hu, X., Xia, F., Lee, J., Li, F., Lu, X., Zhuo, X., Nie, G., & Ling, D. (2021) · Advanced Science · doi:10.1002/advs.202002545 · Cited by 47
Monteleone, L., Speciale, A., Valenti, G. E., Traverso, N., Ravera, S., Garbarino, O., Leardi, R., Farinini, E., Roveri, A., Ursini, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10050691 · Cited by 47
Noguchi, M., Kohno, S., Pellattiero, A., Machida, Y., Shibata, K., Shintani, N., Kohno, T., Gotoh, N., Takahashi, C., Hirao, A., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05768-2 · Cited by 46
Mitochondrial dysfunction and potential anticancer therapy
LLeonart, M. E., Grodzicki, R., Graifer, D. M., & Lyakhovich, A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21459 · Cited by 48
SOX2 as a novel contributor of oxidative metabolism in melanoma cells
Andreucci, E., Pietrobono, S., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., Stecca, B. A., & Calorini, L. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0297-z · Cited by 45
Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cells
Zhang, S., Liu, C., & Zhang, X. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.016 · Cited by 46
RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer
Rao, S., Sigl, V., Wimmer, R., Novatchkova, M., Jaïs, A., Wagner, G., Handschuh, S., Uribesalgo, I., Hagelkrüys, A., Kozieradzki, I., et al. (2017) · Genes & Development · doi:10.1101/gad.304162.117 · Cited by 43
Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
Pendleton, K. E., Wang, K., & Echeverria, G. V. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1254313 · Cited by 48
Metabolism in embryonic and cancer stemness
Jang, H., Yang, J., Lee, E., & Cheong, J. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0558-y · Cited by 50
Kumazoe, M., Takai, M., Hiroi, S., Takeuchi, C., Kadomatsu, M., Nojiri, T., Onda, H., Bae, J., Huang, Y., Takamatsu, K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772111 · Cited by 42
Momcilovic, M., & Shackelford, D. B. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.220 · Cited by 48
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.